A rationale for conducting parallel mechanistic studies in clinical trials of pharmacotherapy.
Becker
Richard C
RC
DCRI, Duke University School of Medicine, 2400 Pratt Street, Durham, NC 27705, USA. becke021@mc.duke.edu
D054316:Biomarkers, Pharmacological / Q000032:analysis*; D002986:Clinical Trials as Topic; D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D025202:Molecular Diagnostic Techniques; D018579:Patient Selection; D010597:Pharmacogenetics; D012107:Research Design; D016896:Treatment Outcome
D054316:Biomarkers, Pharmacological